Devax

Devax, Inc. is a privately-held emerging medical device company based in Irvine, California, dedicated to developing the patented drug-eluting bifurcation stent system AXXESS PLUS, providing clinical solutions for atherosclerotic disease in coronary bifurcation lesions. Devax is currently conducting a pivotal clinical trial to support FDA approval.